Declining Use of Newborn Vitamin K Shot Linked to Higher Risk of Infant Bleeding, Children's Hospital of Philadelphia Study Finds
Analysis of more than 5.2 million hospital births documents dangerous national trend in intramuscular vitamin K administration and underscores potential consequences for infants PHILADELPHIA, Nov. 5, 2026 /PRNewswire/ -- In the largest retrospective study to date, researchers at...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 87 stories mentioning NOV, the earliest published 16 Dec 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.